Prevention of anxiety among at-risk children: a systematic review and meta-analysis by Lawrence, Pete J. et al.
Review: Prevention of anxiety among at-risk
children and adolescents – a systematic review and
meta-analysis
Peter J. Lawrence1, Sally M. Rooke2 & Cathy Creswell1
1School of Psychology and Clinical Language Sciences, University of Reading, Reading, RG6 6AL, UK.
E-mail: p.j.p.lawrence@reading.ac.uk
2Academic Unit of Psychology, University of Southampton, Southampton, SO17 1BJ, UK
Background: Anxiety disorders are common, often start in childhood and run a chronic course. As such there is
a need for effective prevention. Methods: We conducted a systematic review and meta-analyses of random-
ized, controlled trials to prevent the onset of anxiety disorders in ‘at risk’ young people. Diagnostic and symp-
tom outcomes were examined. Putative moderators were tested as was publication bias. Results: We included
16 trials (2545 young people). Two trials reported diagnostic outcomes, and significant effects were found for
these at end-of-programme (RR = .09, 95%CI = .02 to .16), 6- (RR = .17, 95%CI = .06 to .27) and 12-month
(RR = .31, 95%CI .17 to .45) follow-ups. Based on 16 trials, improved anxiety symptoms were significant
compared to nonattention controls only, with small effect sizes reported by young people at the end-of-
programmes, 6- and 12-month follow-ups; and by parents at the end of the programmes and 12-, but not 6-,
month follow-ups. There was no evidence of significant moderation or publication bias. Conclusions: Fourteen
studies included children and young people who presented with elevated anxiety symptoms, but anxiety disor-
der was not ruled out in the participants in these studies. Hence, these studies might be reporting results of
mixed prevention/early intervention programmes. Prevention programmes that target developmental risk fac-
tors, not only disorder maintaining factors, appear most promising. The clinically meaningful impact of anxiety
disorder prevention programmes remains unknown.
Key Practitioner Message
• Prevention programmes appear to have greatest impact where young people are identified based on
multiple risk factors for developing an anxiety disorder.
• Diagnostic outcomes must be assessed to obtain a clearer picture of programme effectiveness.
• Future studies examining modification of risk factors and mediators of change are required.
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Introduction
Anxiety disorders are among the most common mental
health difﬁculties across the life span, with a lifetime
prevalence of 28.8% (Kessler et al., 2005). They com-
monly emerge during childhood or adolescence, with
approximately 50% of those affected ﬁrst experiencing
difﬁculties before 11 years of age (Kessler et al., 2005)
and a worldwide prevalence of 6.5% (Polanczyk, Salum,
Sugaya, Caye, & Rohde, 2015). This high prevalence is
concerning because childhood anxiety disorders often
run a chronic course, are associated with substantial
interference in young peoples’ social, educational and
family lives, and are a risk for the development of other
mental health problems in later life (Bittner et al., 2007;
Pine, Cohen, Gurley, Brook, & Ma, 1998; Woodward &
Fergusson, 2001). Effective interventions for childhood
anxiety disorders have been established (e.g. James,
James, Cowdrey, Soler, & Choke, 2013) but are accessed
by relatively few children and adolescents in need
(Merikangas et al., 2011). Furthermore, a signiﬁcant
minority of those that do access treatments either termi-
nate treatment prematurely or do not beneﬁt (James
et al., 2013). Intervening to prevent the emergence of
anxiety problems among children and young people at
risk of their development brings potential advantages
from intervening before patterns of responding (among
the child and those around them) become ingrained and
more difﬁcult to reverse (Donovan & Spence, 2000), and
by reducing the burden on families and services by mini-
mizing the distress and costs associated with childhood
anxiety disorders, including missed days at school, lost
parent productivity and a broad range of other health
and social care costs (Creswell, Cruddace et al., 2015).
While terms and deﬁnitions vary, mental health pre-
vention has typically been classiﬁed as ‘universal’, ‘selec-
tive’ or ‘indicated’ (e.g. Haggerty & Mrazek, 1994).
Universal prevention targets whole populations that
have not been identiﬁed on the basis of any particular
risk factors, ‘selective’ prevention targets subgroups that
are at risk of developing the target disorder and ‘indi-
cated’ prevention targets those at high risk who have
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detectable symptoms of the disorder (Haggerty & Mra-
zek, 1994). Recent reviews have highlighted the potential
value of prevention across each of these levels for child
internalizing problems (e.g. Stockings et al., 2016), how-
ever, when it comes to anxiety speciﬁcally the ﬁndings
are far from compelling. Of note, the majority of studies
that focus on reducing anxiety were carried out on a uni-
versal basis. In a recent meta-analysis, there was evi-
dence of a signiﬁcant reduction in the risk of anxiety
disorders following universal programmes, however,
only immediately after the intervention (not at later time
points), and there was a high level of heterogeneity
between studies (Stockings et al., 2016). While the effect
size was respectable in relation to other universal inter-
ventions (Relative Risk (RR) = 0.25 95% CI = .01 to .65),
the degree to which clinically meaningful symptoms are
reduced in those that need it remains modest. This
potential limitation of the universal approach was high-
lighted in a recent large, UK study of school-based uni-
versal prevention in which children who had low levels of
anxiety symptoms at baseline reported signiﬁcantly
greater reductions in anxiety following an intervention
delivered by health professionals compared to those who
received the intervention from school staff or received
usual school provision, but there was no signiﬁcant ben-
eﬁt for those who had high scores at baseline and who
might be considered to be at greatest risk of developing a
disorder (Stallard et al., 2014). These ﬁndings might
suggest that, while universal programmes may bring
general beneﬁts in increasing well-being (and potentially
improving mental health awareness) across the broader
community, they might not be effective in reducing the
risk of clinical levels of anxiety among those who are at
risk.
In contrast to universal prevention, selected and indi-
cated prevention target those who are more likely to
develop anxiety disorders on the basis of risk factors (se-
lective) and elevated symptoms (indicated). Recent
reviews have identiﬁed few studies that take this
approach for anxiety speciﬁcally. For example, Stockings
et al. (2016) identiﬁed only one selective study that
assessed the emergence of anxiety disorders, although
nine studies reported on changes in anxiety symptoms.
In both cases, prevention was associated with reduced
anxiety in comparison to (typically inactive) controls
immediately after the intervention, but there was no evi-
dence of ongoing beneﬁts at later time points. In the case
of indicated prevention, again only one study assessed
emergence of anxiety disorders, although this did ﬁnd a
signiﬁcant effect 12 months later. However, on the basis
of the 17 studies that reported on change in anxiety
symptoms, there was no evidence of a signiﬁcant reduc-
tion in symptoms at any assessment time point.
The variability in outcomes across targeted (selective
and indicated) prevention programmes for anxiety may,
at least in part, reﬂect the different criteria by which ‘at
risk’ youth are deﬁned and identiﬁed. Risk factors for the
development of anxiety disorders (and internalizing
problems more broadly) have been examined in only a
small number of longitudinal studies and can be
grouped in to three categories: social-environmental
factors (e.g. socioeconomic status), family factors (e.g.
parental psychopathology, stress, behaviours) and indi-
vidual child factors (e.g. temperament, early symptoma-
tology, attachment). Taking these in turn there is
evidence that low socioeconomic status (SES) at birth
(Leech, Larkby, Day, & Day, 2006) and at age 2–3 years
(Ashford, Smit, Van Lier, Cuijpers, & Koot, 2008) signif-
icantly predict internalizing symptoms at 10–11 years.
In terms of family factors, recent longitudinal studies
that have focused on the development of anxiety disor-
ders speciﬁcally have highlighted a potentially impor-
tant role of parental psychopathology and behaviours.
For example, both Hudson and Dodd (Hudson & Dodd,
2012) and Rapee (2014) found signiﬁcant associations
between maternal anxiety symptoms in preschoolers
and child anxiety disorders at 8–9 years and 15 years
respectively. These ﬁndings are consistent with others
that have found an increased rate of anxiety disorders
among the offspring of parents with anxiety disorders.
In a recent meta-analysis, offspring of parents with
anxiety disorders were found to be at increased risk of
having an anxiety disorder compared to offspring of
parents with no mental disorder (RR = 2.07, 95% CI,
1.73–2.48) and compared to offspring of parents with a
different mental disorder (RR = 1.32, 95% CI, 1.18–
1.49; Lawrence & Creswell, 2016). Hudson and Dodd
(2012) also found a signiﬁcant association between par-
ental overinvolvement when their children were
preschoolers and subsequent child anxiety disorders,
although there was no signiﬁcant association with par-
ental negativity.
In terms of individual child characteristics, the most
widely examined predictor of later anxiety disorders is
behavioural inhibition (BI), the temperamental pattern
characterized by fear and withdrawal in unfamiliar situ-
ations (Degnan & Fox, 2007). For example, in the Hud-
son and Dodd (2012), Rapee (2014) and Frenkel et al.
(2015) studies, high BI among preschoolers predicted
later anxiety disorders. There were a few notable ﬁnd-
ings; in Rapee (2014), high BI only predicted the develop-
ment of social anxiety disorder (whereas high maternal
anxiety predicted both social and other anxiety disor-
ders); in Hudson and Dodd (2012) there was no evidence
that early insecure attachment also predicted later anxi-
ety disorders; and Frenkel et al. (2015) found that high
BI predicted anxiety disorder only for those who, during
adolescence, reported low involvement in socially active
networks.
The extent to which the risk factors associated with
childhood anxiety disorders are independent remains
unclear. For example, family SES may moderate child
risk by its inﬂuence on severity of parental psy-
chopathology, parenting responses, family disruption
and wider stressors (e.g. Beidel & Turner, 1997;
Merikangas, Avenevoli, Dierker, & Grillon, 1999;
Merikangas, Dierker, & Szatmari, 1998). Parental psy-
chopathology (particularly anxiety) may, in turn, raise
the risk of other mechanisms implicated in the develop-
ment of child anxiety (Creswell, Cooper, & Murray,
2015). For example, (Murray et al., 2008) found that
mothers with Social Anxiety Disorder expressed higher
levels of anxiety than nonanxious mothers within a
social referencing paradigm when their child was
10 months, which itself predicted increased infant
avoidance of a stranger 4 months later – particularly
among high BI infants (Murray et al., 2008). These ﬁnd-
ings also highlight the potential interactive nature of
environmental/family factors and child characteristics
in which children who are temperamentally predisposed
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to anxiety/inhibition may be susceptible to other risk
factors in their environment. This suggestion is consis-
tent with the longitudinal ﬁndings of Ashford et al.
(2008) in which there was a cumulative effect of risk fac-
tors measured from 2 years on internalizing problems
measured at 11 years of age. Speciﬁcally, low SES, fam-
ily psychopathology at 2–3 years, and parenting stress
and child internalizing symptoms at 4–5 years each
independently predicted child internalizing problems at
11 years; however, although the presence of one risk fac-
tor was associated with a 15.5% risk (vs. 6.4% risk with
no risk factors), two or more risk factors was associated
with a 48% risk of later internalizing problems. Ashford
et al. (2008) concluded that if these early risk factors
were effectively ameliorated, up to 57% of cases of inter-
nalizing problems among 11 year olds could be avoided.
This systematic review sets out to establish how far
we are towards achieving this goal by reviewing ran-
domized, controlled trials that set out to prevent prob-
lematic levels of child anxiety among ‘at risk’ children.
In line with the literature outlined above we have taken
a broad approach to risk status, including studies that
determine risk on the basis of environmental, family
and/or child characteristics (and as such including
both indicated and selective prevention) and examine
the extent to which the particular risk factor targeted
moderates child outcomes. A broad range of other fac-
tors have been implicated (albeit inconsistently) in the
variability in effectiveness of prevention programmes,
in particular child age, gender and characteristics of
the intervention (i.e. its content, who delivered it, who
it was delivered to and in what format). As such we
have also examined their moderating effects here.
Because of our focus on targeted prevention for ‘at-risk’
children, we have only included studies where these
risks were established for individual children, that is, a
subgroup of children are targeted from within a
broader population; and, because of our focus on pre-
vention, we have also only included studies that do not
include children with identiﬁed anxiety disorders. On
this basis, we examined the following research ques-
tions: (a) Is targeted prevention associated with a
reduction in the onset of anxiety disorders in at-risk
youth; (b) Is targeted prevention associated with a
reduction in anxiety symptom severity in at-risk youth;
(c) Are the effects of targeted prevention moderated by
child age, gender, type and format of intervention, who
delivered and participated in the intervention, and the
type of risk. In all cases, comparisons were conducted
versus both wait list and active control conditions and
both following the intervention and at longer term fol-
low-up time points where available.
Methods
Protocol
Methods of the analysis, inclusion and exclusion criteria were
speciﬁed in advance and documented in a protocol registered on
the International Prospective Register of Systematic Reviews
(PROSPERO; protocol number: CRD42017055312).
Eligibility criteria
Inclusion and exclusion criteria were drafted and then reﬁned
after piloting using a subsample of papers. A study was selected
for inclusion if:
1 It included an active intervention which aimed to reduce
anxiety symptoms and/or prevent the emergence of anxi-
ety disorders in children/adolescents.
2 Its participants were children or adolescents. Studies were
excluded if the mean age of the children/adolescents was
over 18 years or the sample included adults over 21 years.
3 Its participants were selected for inclusion on the basis of
being individually ‘at-risk’ of the development of an anxiety
disorder as included in DSM5. Studies were excluded if
they included children identiﬁed as having an anxiety dis-
order.
4 It reported outcomes using a recognized diagnostic tool for
a DSM5 anxiety disorder, or a validated measure of anxiety
symptoms using standardized scores.
5 It used a Randomized, Controlled Trial (RCT) design to
compare a preventative intervention with a waitlist and/or
an active comparison condition. Studies that provided
qualitative data only and those that did not include any
new data (e.g. reviews) were excluded.
6 It was published in a peer-reviewed journal.
In order to reduce bias, papers written in languages other
than English were not automatically excluded, and instead an
attempt was made to gain the required information in English.
Where this was not possible, these studies were excluded. As
the focus of the review was prevention among children identiﬁed
as being ‘at-risk’ from the general population, studies that
focused on children with intellectual disabilities, neurodevelop-
mental disorders or speciﬁc health conditions were excluded.
Information sources and search terms
The search was performed in October 2016 using the following
electronic databases; Scopus, Ovid, PsycINFO, Pubmed and
CINAHL. Details about the search strategy and syntax for each
database are contained in the protocol available via PROS-
PERO.
No limitations were used for date of publication or language.
The initial search identiﬁed 3070 records (following de-duplica-
tion). A hand search was also completed, including a search of
references from previous reviews with related topics.
Study selection
Two authors (SR and either PL or one of two research assistants)
independently screened the abstracts of all retrieved references
for eligibility. An abstract included by any rater was included in
the full text stage. These articles were then read in full and rated
again by two authors independently (SR, PL). There was 93.5%
agreement on inclusion between raters (Kappa = 0.76). Dis-
agreements were discussed and reviewed by SR, PL and CC,
and an agreement was reached in all cases.
On completion of the selection process (see Figure 1), 16
records were deemed eligible for this review.
Summary of measures
The primary outcomes for this review were anxiety symptom
severity and anxiety diagnosis.
Data extraction
Relevant data for eachmeasure were collated alongside relevant
information about the participants and the intervention.
Table 1 provides a summary of this information (a full list is
available on request).
Synthesis of results
Data extraction and statistical analysis. The R statistical
environment was used for analysis, with the metafor package
for meta-analysis (Viechtbauer, 2010). We conducted meta-
analyses to address all research questions as long as there were
at least two eligible studies; however, if there were less than ﬁve
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eligible studies we required the studies to examine a similar
intervention and use a similar outcomemeasure.
For diagnostic outcome reports, risk ratios (RR) were calcu-
lated. For continuous outcome measures, standardized mean
differences (SMD) were calculated for each trial by subtracting
mean change from pre- to postintervention in the control group
from the mean change from pre- to postintervention in the
experimental group, divided by the pooled standard deviation
for the control and experimental groups at pretreatment (Mor-
ris, 2007). Random and mixed effects models were used in light
of the natural heterogeneity between trials (Higgins & Thomp-
son, 2002), using Hedge’s g as the pooled effect size. To calculate
the impact of heterogeneity between trials, the I2 statistic was
calculated (Higgins, Thompson, Deeks, & Altman, 2003). Only
one study (Dobson, Hopkins, Fata, Scherrer, & Allan, 2010)
reported more than one anxiety symptom outcome [Beck Anxi-
ety Inventory (BAI) and Mood and Anxiety Symptom Question-
naire (MASQ)], and neither of these was used in any of the other
studies so we chose the BAI, on the basis that it appeared to be
the primary measure of anxiety in this study. Metaregressions
were conducted to assess for moderation of effects by continu-
ous (age, number of sessions, proportion of female to male
participants) and categorical [Cognitive Behavioural Therapy
(CBT)] or other treatment, treatment delivered by psychologist,
teacher or other, individual or group format, child-only ses-
sions, or parent involvement) variables.
Coding of study quality. Two authors (SR and PL) indepen-
dently assessed the quality of each study using the quantitative
study quality tool (Kmet, Lee, & Cook, 2004). Domains assessed
include risk of bias and description of study objectives, sample
size, analysis description and reported estimates of variance for
primary outcomes.
Publication bias. The risk of publication bias was assessed
using funnel plots and Egger tests.
Results
Sixteen studies met entry criteria. The Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
(PRISMA) selection ﬂow chart is presented in Figure 1
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Figure 1. Preferred Reporting Items for Sytematic Reviews andMeta-Analyses (PRISMA) flow diagram of selection of studies
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(Moher, Liberati, Tetzlaff, & Altman, 2009). Retained
studies included a total of 2545 participants at risk for
anxiety disorders.
For diagnostic outcomes, only two studies were identi-
ﬁed for inclusion. Risk ratios were calculated and pooled
using a random-effects model. Risk ratios tell us the like-
lihood of an outcome (here, diagnosis of anxiety disorder)
for those receiving a preventative intervention rather
than a control. At each assessment, diagnosis of anxiety
disorder was signiﬁcantly less likely in the group that
had received the prevention programme, and there was
nonsigniﬁcant heterogeneity: at the end of the pro-
gramme (RR = .09, 95%CI = .02 to .16; Q = .52, p = .47,
I2 2 = .00)); at 6-month follow-up (RR = 0.17, 95%
CI = .06 to .27; Q = .013, p = .91, I2 = 0.00); and at
12 month follow-up (RR = .31, 95%CI .17 to .45;
Q = .09, p = .77, I2 = .00; see Figure 2).
When continuous (symptom measure) outcomes were
compared to an inactive control group, young people
reported a signiﬁcant small to moderate (SMD = .43,
95%CI = .73 to .12) effect at the end of the preventive
programme (Figure 3A). There was a large amount of
heterogeneity between studies in this analysis
(Q = 32.67, p < .000, I2 = 72.2%). In comparison to an
attention control, the effect size fell (SMD = .09, 95%
CI = .28 to .10), and was nonsigniﬁcant (Figure 3B).
There was nonsigniﬁcant heterogeneity in this effect
(Q = 1.72, p = .79, I2 = .00). At follow-up assessed up to
6 months after the prevention programme, data were
adequate to allow analysis only for studies with an inac-
tive control group. Where follow-up was conducted
within 6 months of the end of the prevention pro-
gramme, the effect was signiﬁcant (SMD = .46, 95%
CI = .62 to .30), with nonsigniﬁcant heterogeneity
(Q = 3.07, p = .38, I2 = .00). Follow-up assessments
reported beyond 6 months extended to 24 months
(O’Leary-Barrett et al., 2013). There was a signiﬁcant
effect for studies comparing prevention to a wait list con-
trol (SMD = .32, 95%CI = .63 to.01). There was sig-
niﬁcant heterogeneity of effect sizes (Q = 13.23, p < .01,
I2 = 81.89). Forest plots (Figure 3C and D) show the
results of these analyses visually. The analysis of follow-
up of trials with an attention control group was not pos-
sible because only one study (Dobson et al., 2010)
reported these data.
Five studies included parents’ reports on offspring
anxiety symptoms at their end-of-programme evalua-
tions. These were all compared to nonattention controls,
and yielded a small effect size (SMD = .40, 95%
CI = .63 to .17; See Figure 4). There was nonsigniﬁ-
cant heterogeneity (Q = 5.76, p = .22, I2 = 10.6%). Only
two studies included parents’ symptom reports at fol-
low-up assessments. At 6 months, there was a larger,
but nonsigniﬁcant, effect (SMD = .45, 95%CI = .04
to 0.15), and at 12 months, a larger and signiﬁcant effect
(ES = .45, 95%CI = .75 to .15). There was non-
signiﬁcant heterogeneity at both follow-up time points:
at 6 months (Q = 2.92, p = .09, I2 = 65.8%), and at
12 months (Q = .12, p = .73, I2 = 0.0%).
Metaregression analyses showed that none of the
putative moderators had a signiﬁcant impact on the
effect of prevention on symptoms of anxiety reported by
the young people at risk (p = .24 to .93).
Studies varied in terms of quality (see Table S1).
The major concerns across studies were in how
randomization was achieved and the blinding of
researchers and participants to participants’ status (ex-
perimental or control). In addition, studies did not con-
sistently report variance statistics (such as conﬁdence
intervals or standard errors).
Visual inspection of funnel plots and Egger’s intercept
regression tests showed no signiﬁcant evidence of publi-
cation bias for continuous measured outcomes
(z = 1.08, p = .28) (see Figure S1). For diagnostic out-
comes, the Egger test was not conducted (Higgins &
Green, 2011).
Discussion
Our review identiﬁed only two studies that examined the
effect of a prevention programme on the onset of child
anxiety disorders. Findings from these studies were in
the expected direction, with a 91% reduction in risk of
anxiety disorder diagnosis at the end of the programme
and 69% by 12-month follow-up in those who received a
prevention programme (Coping and Promoting Strength,
CAPS) compared to those who did not. More studies com-
pared outcomes based on self- reported anxiety symp-
toms. In this case, there was a small and signiﬁcant
effect compared to a wait list control (based on 10 stud-
ies; SMD = .43) and a small, but insigniﬁcant, effect
compared to an attention control condition at the end of
the intervention (based on ﬁve studies) (SMD = .09).
The effect of prevention programmes increased up to
6 months after the intervention, but then fell at follow-up
assessments between 12 and 24 months. When parents
reported on young people’s anxiety symptoms, effects
were in the small range at each time point compared to
nonattention controls, although were not signiﬁcant at 6-
month follow-ups. Across diagnostic and symptom out-
comes, and self- and parent-reports, there were inade-
quate data to compare outcomes at follow-up to attention
controls. Hence, it remains unclear whether those effects
found compared to waitlist controls are purely a result of
response bias as a result of taking part in a prevention
programme and/or the effects are speciﬁc to a particular
prevention programme.
This meta-analysis is unique in that it has only
included trials where young people were individually
identiﬁed as at-risk and had not been identiﬁed as hav-
ing an anxiety disorder before beginning the prevention
programme. Hence, the results are only indirectly com-
parable to those of previous meta-analyses (Fisak,
Richard, & Mann, 2011; Stockings et al., 2016). For
example, Fisak et al. (2011) included children targeted
on the basis of characteristics of the wider population
rather than the individual participants and found a
mean postintervention effect of .26 across targeted pre-
vention programmes versus wait list controls. Stockings
et al. (2016) considered indicated and selective preven-
tion programmes separately. Selective programmes were
not associated with signiﬁcant reductions in anxiety
diagnoses (RR = .8, 95%CI = .60 to 1.07), although this
was based on only a single study. However, selective pro-
grammes did lead to signiﬁcant reductions in anxiety
symptoms at 1–3 months after the intervention
(ES = .69, 95%CI = 1.08 to .30) compared to active
and assessment only controls; however, signiﬁcant ﬁnd-
ings were based on only one of nine studies and there
were no signiﬁcant effects at longer term follow-up
© 2017 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
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assessments. When it came to indicated prevention pro-
grammes, only one study reported effects on disorder
development, and this was signiﬁcant at 12 months
(RR = .31, 95%CI = .1 to .98). There was no signiﬁcant
reduction in anxiety symptoms in the indicated pro-
grammes at any assessment time point. Notably the
Stockings et al. (2016) review included some studies
with children identiﬁed as having an anxiety disorder
before beginning treatment (Dadds, Spence, Holland,
Barrett, & Laurens, 1997; Rapee, Kennedy, Ingram,
Edwards, & Sweeney, 2005; Simon, Bogels, & Voncken,
2011). Despite some differences in the approach
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Figure 2. Forest plots of meta-analysis of effects of Anxiety Disorder prevention programmes on Anxiety Disorder diagnostic outcomes.
Note: A: end-of-programme; B: 6-month follow-up; C: 12-month follow-up
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Figure 3. Forest plots of meta-analysis of effects of Anxiety Disorder prevention programmes on self-reported anxiety symptoms. Note: A:
end-of-programme versus waitlist control; B: end-of-programme versus active control; C: 6-month follow-up; versus waitlist control; D:
12–24-month follow-up versus waitlist control
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Figure 4. Forest plots of meta-analysis of Anxiety Disorder prevention programmes on parent report of anxiety symptoms. Note: A: end-
of-programme; B: 6-month follow-up; C: 12-month follow-up
© 2017 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
Adolescent Mental Health.
doi:10.1111/camh.12226 Meta-analysis of secondary anxiety prevention 9
followed, the results from our analyses compare favour-
ably to those of previous analyses in terms of diagnostic
and symptom severity outcomes.
Identifying risk
The studies included in this review identiﬁed children at
risk of anxiety disorders on the basis of family factors
(parental anxiety disorder) and child factors (heightened
anxiety symptoms and sensitivity and being the victim of
bullying). None of the studies that we identiﬁed targeted
children on the basis of their individual socioenviron-
mental risk. Rather, where SES was addressed, children
were drawn from samples where, for example, partici-
pants attended a school where a signiﬁcant number of
children had low family incomes (for example, Mifsud &
Rapee, 2005). It is also important to note that only one
study identiﬁed at-risk children on the basis of more
than one risk factor (Berry & Hunt, 2009) given evidence
from Ashford et al. (2008) regarding cumulative risks
leading to signiﬁcantly worse outcomes.
Modifying risk
What we know about risk has not always informed the
content of prevention programmes. For example, inter-
ventions have not typically actively set out to alter the
characteristics which identiﬁed children as ‘at risk’, for
example, socioeconomic deprivation, parent anxiety dis-
order. Instead, interventions have often targeted factors
that are presumed to maintain anxiety disorders (e.g.
Kosters, Chinapaw, Zwaanswijk, van der Wal, & Koot,
2015; Miller et al., 2011) or to improve resilience (e.g.
Hiebert, Kirby, & Jaknavorian, 1989). Furthermore,
many prevention programmes have omitted a focus on
modiﬁcation of evidenced risk factors such as parent–
child interactions (Majdandzic, Moller, de Vente, Bogels,
& van den Boom, 2014; Murray et al., 2008; Rubin, Nel-
son, Hastings, & Asendorpf, 1999). A clear exception to
this is the CAPS programme (Ginsburg, 2009; Ginsburg,
Drake, Tein, Teetsel, & Riddle, 2015), where parent risk
factors, such as anxiety-enhancing behaviours, are an
explicit target.
Clinical implications
Clinically, the strongest results of the studies included
in the review were from Ginsburg (2009); Ginsburg et al.
(2015), where the CAPS programme showed signiﬁcant
preventive effects against the onset of anxiety disorder at
the end of the programme (91%) and 12 months later
(69%), and the reduced risk exceeded the target of 57%
set by Ashford et al. (2008) despite children being identi-
ﬁed as at-risk on the basis of one risk factor (parental
anxiety disorder). The CAPS programme explicitly tar-
gets established risk factors for the development of anxi-
ety disorder such as parental modelling of anxious
behaviours and anxiety-enhancing parental responses
(Ginsburg, 2009). It is highly plausible that targeting
these risk factors accounts for the programme’s effec-
tiveness, although this has not been directly examined.
Notable outcomes from other studies include those
from Siu (2007) and Berry and Hunt (2009), which both
reported large effect sizes (g = 1.46, 95%CI 2.1 to
.81; g = 1.18, 95%CI = 1.8 to .55 respectively) on
symptoms at the end of the programme compared to a
waitlist control; and Mifsud and Rapee (2005), where
medium effect sizes (g = .63, 95%CI = 1.05 to .2) on
symptom measures were reported by young people at 6-
month follow-up. Siu (2007) examined the CBT-based
FRIENDS programme with children identiﬁed on the
basis of elevated self-reported internalizing symptoms in
Hong Kong and the ﬁndings highlight the promise of pre-
vention programmes in cultures where CBT-based pro-
grammes have to date received relatively little attention.
The other two notable studies included participants on
the basis of two risk factors. Speciﬁcally, Berry and Hunt
(2009) identiﬁed participants on the basis of elevated
anxiety symptoms and being victims of bullying; and
Mifsud and Rapee (2005) identiﬁed participants on the
basis of elevated anxiety symptoms and attending a
school in a socioeconomically disadvantaged areas
(although some of these young people might not have
individually been socioeconomically disadvantaged). The
positive results from these two studies are consistent
with the results of Ashford et al. (2008) in that preven-
tion programmes might be most beneﬁcial to those with
multiple risk factors for the development of anxiety
although this has not been directly tested.
Limitations of included studies
The absence of assessment of anxiety diagnoses from 14
of the 16 studies means that the central question of this
meta-analysis regarding the prevention of anxiety disor-
ders in at-risk youth has been addressed by only two
studies, and our conﬁdence in our answer is commensu-
rately limited. This limitation also means that many
studies are likely to have included children who would
have been identiﬁed as having an anxiety disorder at
baseline had this been assessed. For example, in the
study by Kosters et al. (2015), mean anxiety symptom
score was between 1.5 and 2 standard deviations above
the general population. This suggests that, even though
none of the children was identiﬁed as having an anxiety
disorder, had they been assessed against diagnostic cri-
teria, many might have met them. Given this, our results
should be treated with caution because, although we
have excluded those with identiﬁed anxiety disorders,
we were naturally unable to exclude those with unidenti-
ﬁed anxiety disorders. It is of note that the two studies
that did formally establish that all children did not have
anxiety disorders at the outset (Ginsburg, 2009; Gins-
burg et al., 2015) were the same two studies identiﬁed
on the basis of parental anxiety disorder and where effect
sizes were relatively high.
The majority of studies that reported on symptoms as
outcomes, were most frequently only child self-reports.
Recent studies show that parent report is a better pre-
dictor of anxiety diagnostic status than child report, at
least with children up to 13 years of age (Evans, Thirl-
wall, Cooper, & Creswell, 2016; Villabø, Gere, Torgersen,
March, & Kendall, 2012). Furthermore, studies invari-
ably only reported on mean anxiety symptoms, so we
were unable to assess the frequency of cases where there
was a clinically meaningful impact on children’s anxiety
symptoms.
The content and format of prevention programmes
varied across studies. For example, six studies reported
a provision for parent involvement in their prevention
programme although two of these reports did not specify
the rates of parent involvement (i.e. stating only that par-
ents were invited to participate in two sessions, not
whether any did). As such, our ﬁnding that parent
© 2017 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
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involvement did not moderate the effectiveness of pre-
vention programmes needs to be interpreted with cau-
tion. Programmes also differed in their inclusion of
booster sessions beyond the end of the programme, with
the majority (13) including no booster sessions. From
the adult literature on the treatment of anxiety disorders
(Craske et al., 2006, 2009), booster sessions appear to
contribute positively to outcomes and this is a clear area
for further evaluation.
Studies also differed in key methodological character-
istics. Twelve studies used a nonattention control group
for comparison to the prevention group; in nine, a wait-
list. An active control was used in ﬁve studies. There was
variability in what the attention control groups received:
for example, group discussions of topics of interest to
adolescents, such as role models, drugs and alcohol
(Dobson et al., 2010); being read an adventure story
such asHarry Potter in small groups (Miller et al., 2011);
or biofeedback training (Hiebert et al., 1989). Despite
longer term outcomes being of particular interest in pre-
ventive efforts, follow-up assessments were only
included in seven studies (only one of which had an
attention control) and ranged from 3 to 24 months. As
such our analyses are grouped, arguably arbitrarily, by
those that occurred up to 6 months after the end of the
prevention programme and between 12 and 24 months.
The relative absence of long-term follow-up inmost stud-
ies severely limits our ability to reach conclusions about
preventive effects.
Limitations of our review
The conclusions we have been able to draw from our
analyses are unable to support ﬁrm answers to central
questions, including whether programmes to prevent
the onset of anxiety disorders for children and young
people identiﬁed as at risk of developing anxiety disor-
ders are effective. Evidence is tentative at best, being
based on only two studies. Our conclusions regarding
the effectiveness of programmes where anxiety symp-
toms (not disorders) were assessed are limited in two
important ways. First, it is very likely some participants,
had they been assessed for anxiety disorders, would
have met criteria for a diagnosis of at least one anxiety
disorder. This is important because it means the pro-
grammes could have been functioning as both preven-
tion and early intervention, clouding the picture about
effectiveness as prevention programmes. Second, we
have been unable to examine study data at the partici-
pant level. This is important because it means we have
only been able to analyse whether symptom changes
were greater in one group or the other (or neither), but
not whether either or both groups reported clinically
meaningful symptom changes.
We were unable to evaluate whether particular inter-
ventions were of particular beneﬁt due to the varied ways
in which they were delivered. For example, the FRIENDS
programme was administered in 5 of 11 CBT studies;
however, it varied in terms of the number of sessions,
number of participants per group, participant ages and
inclusion of booster sessions. As such, in some cases,
FRIENDS programmes may have been more similar to
the non-FRIENDS comparator than to other versions of
FRIENDS.
Unfortunately three potentially eligible reports were
inaccessible so could not be included in the review. We
were also limited by a lack of available data to fully evalu-
ate moderators. For example, age ranges were typically
broad and as such the mean age limits the clarity of the
picture that results from this analysis. Moderation on
the basis of risk factor was also limited to elevated anxi-
ety symptoms, heightened anxiety sensitivity, parent
anxiety disorder and being a victim of bullying and none
of the other risk factors for the development of anxiety
disorders, including individual socioeconomic status
(Leech et al., 2006); parent–child interactions character-
ized by anxiety (Murray et al., 2014), child behavioural
inhibition (Fox et al., 2005) and, possibly even more
informatively, combinations of these individual risk fac-
tors (Hudson & Rapee, 2004; Kennedy, Rapee, &
Edwards, 2009; Rubin, Coplan, & Bowker, 2009). Nota-
bly, studies that have intervened with children with ele-
vated behavioural inhibition have been conducted, with
favourable results, but were excluded from this review
because many of the children identiﬁed as at-risk had
already developed anxiety disorders (e.g. Kennedy et al.,
2009; Rapee, 2013).
What to do in future studies
The ﬁndings of this review lead to key suggestions for
future anxiety disorder prevention studies. First, diag-
nostic status must be assessed before and after the pre-
vention programme so we can draw conclusions about
whether the programmes actually prevent the onset of
anxiety disorders. Second, studies should directly exam-
ine the potential enhanced effects of prevention by iden-
tifying young people for inclusion on the basis of more
than one evidence-based risk factor. Third, prevention
programmes must not only include those identiﬁed as at
most risk, but must then target the malleable risk fac-
tors that place them at risk. Eleven studies analysed
used programmes based on generic cognitive beha-
vioural models of maintenance of anxiety disorders with-
out additional components to address known risk
factors. Programmes excluded from this review (because
children had already developed anxiety disorders at
baseline) such as Kennedy et al. (2009) have shown the
feasibility and effectiveness of this approach; they not
only identiﬁed children on the basis of more than one
risk factor (behavioural inhibition and parent anxiety
disorder) but also targeted these risk factors directly in
their programme. At follow-up, the intervention group
not only showed signiﬁcantly fewer anxiety disorders but
also less behavioural inhibition. Prevention programmes
that modify malleable risk factors bring the prospect of
the scientiﬁc beneﬁt of testing putative mechanisms of
development of (causal risk factors for) anxiety disor-
ders. Fourth, no studies included identiﬁed children as
being at risk of any speciﬁc anxiety disorder, rather than
anxiety disorders generally. Programmes have therefore
not drawn on the evidence that some risk factors such as
behavioural inhibition (Rapee, 2014) might predict the
risk of speciﬁc anxiety disorders, rather than anxiety
disorders in general. Finally, it is essential that clinicians
and researchers work closely with families to determine
the optimal time, both scientiﬁcally and practically, to
intervene to prevent the onset of anxiety disorders – criti-
cally this needs to be at a time that feels relevant to fami-
lies and at which they would be willing to engage in
preventive interventions and in a way that is acceptable
to families and does not feel stigmatising. As a group,
© 2017 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and
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studies on prevention of anxiety disorders among at-risk
children show promise and there are some isolated stud-
ies with compelling results (e.g. Ginsburg et al., 2015)
but clearly, much work remains to be done to identify
those children most at risk, to know how best to effec-
tively modify those risk factors to test the causal status
of risk factors, and to ultimately alter the developmental
trajectories of speciﬁc anxiety disorders.
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